Kaufmann Gunnar F. 4/A
4/A · Oncternal Therapeutics, Inc. · Filed Jul 31, 2020
Insider Transaction Report
Form 4/AAmended
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Stock Option
2020-03-17+14,260→ 14,260 totalExercise: $3.33Exp: 2030-03-17→ Common Stock (14,260 underlying)
Footnotes (2)
- [F1]The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
- [F2]Fully vested on grant date.